Reduced apoptosis by pentoxiphylline among patients with HIV infection

Ajay Wanchu, A. Bhatnagar, B. Kumar, P. Bambery, S. Singh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Apoptosis is a significant cause of CD4+ T cell death. Caspase 8 (FLICE) is involved in apoptosis mediated by Fas and p55 tumor necrosis factor (TNF) receptor ligation. It is also partially mediated by interleukin-1beta (IL-1β)-converting enzyme (ICE; caspase 1). We and others have shown that pentoxiphylline inhibits TNF-α. We used it among patients with HIV infection to determine if 24 weeks of therapy altered the levels of caspase 1 and caspase 8. Patients and methods: Nineteen HIV-infected patients having no opportunistic infection at the time of recruitment were administered pentoxiphylline 400 mg thrice daily for 24 weeks. Caspase levels were measured using a single-step ELISA using commercially available monoclonal antibodies against caspase 1 and caspase 8. Results: Mean CD4 counts of the patients were 202.6±111.6 (/mm3). Mean OD value of caspase 1 among patients before therapy was 0.302±0.197 and was higher than that of controls (0.287±0.064), but this was not statistically significant. Following 24 weeks of therapy with pentoxiphylline, the OD value declined significantly to 0.164±0.028 among patients (p

Original languageEnglish (US)
Pages (from-to)359-364
Number of pages6
JournalInternational Immunopharmacology
Volume3
Issue number3
DOIs
StatePublished - Mar 2003
Externally publishedYes

Fingerprint

Caspase 1
HIV Infections
Apoptosis
Caspase 8
Tumor Necrosis Factor Receptors
Opportunistic Infections
CD4 Lymphocyte Count
Caspases
Ligation
Cell Death
Therapeutics
Tumor Necrosis Factor-alpha
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
HIV
T-Lymphocytes

Keywords

  • Caspase
  • HIV infection
  • Pentoxiphylline

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Reduced apoptosis by pentoxiphylline among patients with HIV infection. / Wanchu, Ajay; Bhatnagar, A.; Kumar, B.; Bambery, P.; Singh, S.

In: International Immunopharmacology, Vol. 3, No. 3, 03.2003, p. 359-364.

Research output: Contribution to journalArticle

Wanchu, Ajay ; Bhatnagar, A. ; Kumar, B. ; Bambery, P. ; Singh, S. / Reduced apoptosis by pentoxiphylline among patients with HIV infection. In: International Immunopharmacology. 2003 ; Vol. 3, No. 3. pp. 359-364.
@article{b176b6dbe7734859a13162522dc79053,
title = "Reduced apoptosis by pentoxiphylline among patients with HIV infection",
abstract = "Background: Apoptosis is a significant cause of CD4+ T cell death. Caspase 8 (FLICE) is involved in apoptosis mediated by Fas and p55 tumor necrosis factor (TNF) receptor ligation. It is also partially mediated by interleukin-1beta (IL-1β)-converting enzyme (ICE; caspase 1). We and others have shown that pentoxiphylline inhibits TNF-α. We used it among patients with HIV infection to determine if 24 weeks of therapy altered the levels of caspase 1 and caspase 8. Patients and methods: Nineteen HIV-infected patients having no opportunistic infection at the time of recruitment were administered pentoxiphylline 400 mg thrice daily for 24 weeks. Caspase levels were measured using a single-step ELISA using commercially available monoclonal antibodies against caspase 1 and caspase 8. Results: Mean CD4 counts of the patients were 202.6±111.6 (/mm3). Mean OD value of caspase 1 among patients before therapy was 0.302±0.197 and was higher than that of controls (0.287±0.064), but this was not statistically significant. Following 24 weeks of therapy with pentoxiphylline, the OD value declined significantly to 0.164±0.028 among patients (p",
keywords = "Caspase, HIV infection, Pentoxiphylline",
author = "Ajay Wanchu and A. Bhatnagar and B. Kumar and P. Bambery and S. Singh",
year = "2003",
month = "3",
doi = "10.1016/S1567-5769(02)00252-7",
language = "English (US)",
volume = "3",
pages = "359--364",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Reduced apoptosis by pentoxiphylline among patients with HIV infection

AU - Wanchu, Ajay

AU - Bhatnagar, A.

AU - Kumar, B.

AU - Bambery, P.

AU - Singh, S.

PY - 2003/3

Y1 - 2003/3

N2 - Background: Apoptosis is a significant cause of CD4+ T cell death. Caspase 8 (FLICE) is involved in apoptosis mediated by Fas and p55 tumor necrosis factor (TNF) receptor ligation. It is also partially mediated by interleukin-1beta (IL-1β)-converting enzyme (ICE; caspase 1). We and others have shown that pentoxiphylline inhibits TNF-α. We used it among patients with HIV infection to determine if 24 weeks of therapy altered the levels of caspase 1 and caspase 8. Patients and methods: Nineteen HIV-infected patients having no opportunistic infection at the time of recruitment were administered pentoxiphylline 400 mg thrice daily for 24 weeks. Caspase levels were measured using a single-step ELISA using commercially available monoclonal antibodies against caspase 1 and caspase 8. Results: Mean CD4 counts of the patients were 202.6±111.6 (/mm3). Mean OD value of caspase 1 among patients before therapy was 0.302±0.197 and was higher than that of controls (0.287±0.064), but this was not statistically significant. Following 24 weeks of therapy with pentoxiphylline, the OD value declined significantly to 0.164±0.028 among patients (p

AB - Background: Apoptosis is a significant cause of CD4+ T cell death. Caspase 8 (FLICE) is involved in apoptosis mediated by Fas and p55 tumor necrosis factor (TNF) receptor ligation. It is also partially mediated by interleukin-1beta (IL-1β)-converting enzyme (ICE; caspase 1). We and others have shown that pentoxiphylline inhibits TNF-α. We used it among patients with HIV infection to determine if 24 weeks of therapy altered the levels of caspase 1 and caspase 8. Patients and methods: Nineteen HIV-infected patients having no opportunistic infection at the time of recruitment were administered pentoxiphylline 400 mg thrice daily for 24 weeks. Caspase levels were measured using a single-step ELISA using commercially available monoclonal antibodies against caspase 1 and caspase 8. Results: Mean CD4 counts of the patients were 202.6±111.6 (/mm3). Mean OD value of caspase 1 among patients before therapy was 0.302±0.197 and was higher than that of controls (0.287±0.064), but this was not statistically significant. Following 24 weeks of therapy with pentoxiphylline, the OD value declined significantly to 0.164±0.028 among patients (p

KW - Caspase

KW - HIV infection

KW - Pentoxiphylline

UR - http://www.scopus.com/inward/record.url?scp=0037333925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037333925&partnerID=8YFLogxK

U2 - 10.1016/S1567-5769(02)00252-7

DO - 10.1016/S1567-5769(02)00252-7

M3 - Article

VL - 3

SP - 359

EP - 364

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 3

ER -